ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Vaccines Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-19F793
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global RNA Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global RNA Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-19F793
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

RNA Vaccines Market

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
The global RNA Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for RNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for RNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for RNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of RNA Vaccines include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for RNA Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of RNA Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for RNA Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the RNA Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global RNA Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for RNA Vaccines sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of RNA Vaccines Market Report

Report Metric Details
Report Name RNA Vaccines Market
Segment by Type
Segment by Application
  • Infectious Disease
  • Cancer
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of RNA Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of RNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Vaccines sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Vaccines Market report?

Ans: The main players in the RNA Vaccines Market are Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

What are the Application segmentation covered in the RNA Vaccines Market report?

Ans: The Applications covered in the RNA Vaccines Market report are Infectious Disease, Cancer, Other

What are the Type segmentation covered in the RNA Vaccines Market report?

Ans: The Types covered in the RNA Vaccines Market report are Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine

Recommended Reports

RNA-based Therapeutics

Infectious Disease Vaccines

Cancer and Specialty Vaccines

1 Study Coverage
1.1 RNA Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global RNA Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market by Application
1.3.1 Global RNA Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global RNA Vaccines Sales Estimates and Forecasts 2019-2030
2.2 Global RNA Vaccines Revenue by Region
2.2.1 Global RNA Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global RNA Vaccines Revenue by Region (2019-2024)
2.2.3 Global RNA Vaccines Revenue by Region (2025-2030)
2.2.4 Global RNA Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global RNA Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global RNA Vaccines Sales by Region
2.4.1 Global RNA Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global RNA Vaccines Sales by Region (2019-2024)
2.4.3 Global RNA Vaccines Sales by Region (2025-2030)
2.4.4 Global RNA Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global RNA Vaccines Sales by Manufacturers
3.1.1 Global RNA Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global RNA Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Vaccines in 2023
3.2 Global RNA Vaccines Revenue by Manufacturers
3.2.1 Global RNA Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global RNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by RNA Vaccines Revenue in 2023
3.3 Global Key Players of RNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global RNA Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of RNA Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of RNA Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of RNA Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Vaccines Sales by Type
4.1.1 Global RNA Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global RNA Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global RNA Vaccines Sales Market Share by Type (2019-2030)
4.2 Global RNA Vaccines Revenue by Type
4.2.1 Global RNA Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global RNA Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global RNA Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global RNA Vaccines Price by Type
4.3.1 Global RNA Vaccines Price by Type (2019-2024)
4.3.2 Global RNA Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global RNA Vaccines Sales by Application
5.1.1 Global RNA Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global RNA Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global RNA Vaccines Sales Market Share by Application (2019-2030)
5.2 Global RNA Vaccines Revenue by Application
5.2.1 Global RNA Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global RNA Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global RNA Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global RNA Vaccines Price by Application
5.3.1 Global RNA Vaccines Price by Application (2019-2024)
5.3.2 Global RNA Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada RNA Vaccines Market Size by Type
6.1.1 US & Canada RNA Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada RNA Vaccines Revenue by Type (2019-2030)
6.2 US & Canada RNA Vaccines Market Size by Application
6.2.1 US & Canada RNA Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada RNA Vaccines Revenue by Application (2019-2030)
6.3 US & Canada RNA Vaccines Market Size by Country
6.3.1 US & Canada RNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada RNA Vaccines Sales by Country (2019-2030)
6.3.3 US & Canada RNA Vaccines Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe RNA Vaccines Market Size by Type
7.1.1 Europe RNA Vaccines Sales by Type (2019-2030)
7.1.2 Europe RNA Vaccines Revenue by Type (2019-2030)
7.2 Europe RNA Vaccines Market Size by Application
7.2.1 Europe RNA Vaccines Sales by Application (2019-2030)
7.2.2 Europe RNA Vaccines Revenue by Application (2019-2030)
7.3 Europe RNA Vaccines Market Size by Country
7.3.1 Europe RNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe RNA Vaccines Sales by Country (2019-2030)
7.3.3 Europe RNA Vaccines Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China RNA Vaccines Market Size
8.1.1 China RNA Vaccines Sales (2019-2030)
8.1.2 China RNA Vaccines Revenue (2019-2030)
8.2 China RNA Vaccines Market Size by Application
8.2.1 China RNA Vaccines Sales by Application (2019-2030)
8.2.2 China RNA Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia RNA Vaccines Market Size by Type
9.1.1 Asia RNA Vaccines Sales by Type (2019-2030)
9.1.2 Asia RNA Vaccines Revenue by Type (2019-2030)
9.2 Asia RNA Vaccines Market Size by Application
9.2.1 Asia RNA Vaccines Sales by Application (2019-2030)
9.2.2 Asia RNA Vaccines Revenue by Application (2019-2030)
9.3 Asia RNA Vaccines Sales by Region
9.3.1 Asia RNA Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia RNA Vaccines Revenue by Region (2019-2030)
9.3.3 Asia RNA Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America RNA Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America RNA Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America RNA Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America RNA Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America RNA Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America RNA Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America RNA Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America RNA Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America RNA Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America RNA Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Information
11.1.2 Moderna Therapeutics Overview
11.1.3 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Moderna Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac Overview
11.2.3 CureVac RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CureVac RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Information
11.3.2 Translate Bio Overview
11.3.3 Translate Bio RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Translate Bio RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech Overview
11.4.3 BioNTech RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 BioNTech RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Information
11.5.2 Sangamo Therapeutics Overview
11.5.3 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sangamo Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Information
11.6.2 Argos Therapeutics Overview
11.6.3 Argos Therapeutics RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Argos Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Information
11.7.2 In-Cell-Art Overview
11.7.3 In-Cell-Art RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 In-Cell-Art RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Information
11.8.2 eTheRNA Overview
11.8.3 eTheRNA RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 eTheRNA RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Company Information
11.9.2 Ethris Overview
11.9.3 Ethris RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Ethris RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Information
11.10.2 Tiba Biotechnology Overview
11.10.3 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Tiba Biotechnology RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiba Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Vaccines Industry Chain Analysis
12.2 RNA Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Vaccines Production Mode & Process
12.4 RNA Vaccines Sales and Marketing
12.4.1 RNA Vaccines Sales Channels
12.4.2 RNA Vaccines Distributors
12.5 RNA Vaccines Customers
13 Market Dynamics
13.1 RNA Vaccines Industry Trends
13.2 RNA Vaccines Market Drivers
13.3 RNA Vaccines Market Challenges
13.4 RNA Vaccines Market Restraints
14 Key Findings in The Global RNA Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
List of Tables
    Table 1. Global RNA Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
    Table 3. Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
    Table 4. Major Manufacturers of Infection Prevention MRNA Vaccine
    Table 5. Global RNA Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global RNA Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global RNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global RNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global RNA Vaccines Revenue Market Share by Region (2019-2024)
    Table 10. Global RNA Vaccines Revenue Market Share by Region (2025-2030)
    Table 11. Global RNA Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global RNA Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 13. Global RNA Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 14. Global RNA Vaccines Sales Market Share by Region (2019-2024)
    Table 15. Global RNA Vaccines Sales Market Share by Region (2025-2030)
    Table 16. Global RNA Vaccines Sales by Manufacturers (2019-2024) & (K Doses)
    Table 17. Global RNA Vaccines Sales Share by Manufacturers (2019-2024)
    Table 18. Global RNA Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global RNA Vaccines Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of RNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. RNA Vaccines Price by Manufacturers 2019-2024 (USD/Dose)
    Table 22. Global RNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global RNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Vaccines as of 2023)
    Table 24. Global Key Manufacturers of RNA Vaccines, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of RNA Vaccines, Product Offered and Application
    Table 26. Global Key Manufacturers of RNA Vaccines, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 29. Global RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 30. Global RNA Vaccines Sales Share by Type (2019-2024)
    Table 31. Global RNA Vaccines Sales Share by Type (2025-2030)
    Table 32. Global RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global RNA Vaccines Revenue Share by Type (2019-2024)
    Table 35. Global RNA Vaccines Revenue Share by Type (2025-2030)
    Table 36. RNA Vaccines Price by Type (2019-2024) & (USD/Dose)
    Table 37. Global RNA Vaccines Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 38. Global RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 39. Global RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 40. Global RNA Vaccines Sales Share by Application (2019-2024)
    Table 41. Global RNA Vaccines Sales Share by Application (2025-2030)
    Table 42. Global RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global RNA Vaccines Revenue Share by Application (2019-2024)
    Table 45. Global RNA Vaccines Revenue Share by Application (2025-2030)
    Table 46. RNA Vaccines Price by Application (2019-2024) & (USD/Dose)
    Table 47. Global RNA Vaccines Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 48. US & Canada RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 49. US & Canada RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 50. US & Canada RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 53. US & Canada RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 54. US & Canada RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada RNA Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada RNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada RNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada RNA Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 60. US & Canada RNA Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 61. Europe RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 62. Europe RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 63. Europe RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 66. Europe RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 67. Europe RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe RNA Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe RNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe RNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe RNA Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 73. Europe RNA Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 74. China RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 75. China RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 76. China RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 79. China RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 80. China RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 83. Asia RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 84. Asia RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 87. Asia RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 88. Asia RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia RNA Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia RNA Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia RNA Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia RNA Vaccines Sales by Region (2019-2024) & (K Doses)
    Table 94. Asia RNA Vaccines Sales by Region (2025-2030) & (K Doses)
    Table 95. Middle East, Africa and Latin America RNA Vaccines Sales by Type (2019-2024) & (K Doses)
    Table 96. Middle East, Africa and Latin America RNA Vaccines Sales by Type (2025-2030) & (K Doses)
    Table 97. Middle East, Africa and Latin America RNA Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America RNA Vaccines Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America RNA Vaccines Sales by Application (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America RNA Vaccines Sales by Application (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America RNA Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America RNA Vaccines Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America RNA Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America RNA Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America RNA Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America RNA Vaccines Sales by Country (2019-2024) & (K Doses)
    Table 107. Middle East, Africa and Latin America RNA Vaccines Sales by Country (2025-2030) & (K Doses)
    Table 108. Moderna Therapeutics Company Information
    Table 109. Moderna Therapeutics Description and Major Businesses
    Table 110. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 111. Moderna Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Moderna Therapeutics Recent Developments
    Table 113. CureVac Company Information
    Table 114. CureVac Description and Major Businesses
    Table 115. CureVac RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 116. CureVac RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. CureVac Recent Developments
    Table 118. Translate Bio Company Information
    Table 119. Translate Bio Description and Major Businesses
    Table 120. Translate Bio RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 121. Translate Bio RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Translate Bio Recent Developments
    Table 123. BioNTech Company Information
    Table 124. BioNTech Description and Major Businesses
    Table 125. BioNTech RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 126. BioNTech RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. BioNTech Recent Developments
    Table 128. Sangamo Therapeutics Company Information
    Table 129. Sangamo Therapeutics Description and Major Businesses
    Table 130. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 131. Sangamo Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sangamo Therapeutics Recent Developments
    Table 133. Argos Therapeutics Company Information
    Table 134. Argos Therapeutics Description and Major Businesses
    Table 135. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 136. Argos Therapeutics RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Argos Therapeutics Recent Developments
    Table 138. In-Cell-Art Company Information
    Table 139. In-Cell-Art Description and Major Businesses
    Table 140. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 141. In-Cell-Art RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. In-Cell-Art Recent Developments
    Table 143. eTheRNA Company Information
    Table 144. eTheRNA Description and Major Businesses
    Table 145. eTheRNA RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 146. eTheRNA RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. eTheRNA Recent Developments
    Table 148. Ethris Company Information
    Table 149. Ethris Description and Major Businesses
    Table 150. Ethris RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 151. Ethris RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Ethris Recent Developments
    Table 153. Tiba Biotechnology Company Information
    Table 154. Tiba Biotechnology Description and Major Businesses
    Table 155. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 156. Tiba Biotechnology RNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Tiba Biotechnology Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. RNA Vaccines Distributors List
    Table 161. RNA Vaccines Customers List
    Table 162. RNA Vaccines Market Trends
    Table 163. RNA Vaccines Market Drivers
    Table 164. RNA Vaccines Market Challenges
    Table 165. RNA Vaccines Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. RNA Vaccines Product Picture
    Figure 2. Global RNA Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global RNA Vaccines Market Share by Type in 2023 & 2030
    Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture
    Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture
    Figure 6. Infection Prevention MRNA Vaccine Product Picture
    Figure 7. Global RNA Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global RNA Vaccines Market Share by Application in 2023 & 2030
    Figure 9. Infectious Disease
    Figure 10. Cancer
    Figure 11. Other
    Figure 12. RNA Vaccines Report Years Considered
    Figure 13. Global RNA Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global RNA Vaccines Revenue 2019-2030 (US$ Million)
    Figure 15. Global RNA Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global RNA Vaccines Revenue Market Share by Region (2019-2030)
    Figure 17. Global RNA Vaccines Sales 2019-2030 ((K Doses)
    Figure 18. Global RNA Vaccines Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada RNA Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 20. US & Canada RNA Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe RNA Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 22. Europe RNA Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China RNA Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 24. China RNA Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) RNA Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 26. Asia (excluding China) RNA Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America RNA Vaccines Sales YoY (2019-2030) & (K Doses)
    Figure 28. Middle East, Africa and Latin America RNA Vaccines Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The RNA Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of RNA Vaccines in the World: Market Share by RNA Vaccines Revenue in 2023
    Figure 31. Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 33. Global RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 34. Global RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 35. Global RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada RNA Vaccines Revenue Share by Country (2019-2030)
    Figure 41. US & Canada RNA Vaccines Sales Share by Country (2019-2030)
    Figure 42. U.S. RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 45. Europe RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 46. Europe RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 47. Europe RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 48. Europe RNA Vaccines Revenue Share by Country (2019-2030)
    Figure 49. Europe RNA Vaccines Sales Share by Country (2019-2030)
    Figure 50. Germany RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 51. France RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 55. China RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 56. China RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 57. China RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 58. China RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 59. Asia RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 60. Asia RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 61. Asia RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 62. Asia RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 63. Asia RNA Vaccines Revenue Share by Region (2019-2030)
    Figure 64. Asia RNA Vaccines Sales Share by Region (2019-2030)
    Figure 65. Japan RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 69. India RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America RNA Vaccines Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America RNA Vaccines Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America RNA Vaccines Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America RNA Vaccines Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America RNA Vaccines Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America RNA Vaccines Sales Share by Country (2019-2030)
    Figure 76. Brazil RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries RNA Vaccines Revenue (2019-2030) & (US$ Million)
    Figure 81. RNA Vaccines Value Chain
    Figure 82. RNA Vaccines Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global mRNA Vaccines Therapeutics Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
Global Nucleic Vaccine Market Insights Forecast to 2030
Global Nucleic Acid Vaccine Market Insights Forecast to 2030
Global RNA Sequencing Technologies Market Insights Forecast to 2030
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Technologies for Delivery of Proteins Antibodies and Nucleic Acids Market Insights Forecast to 2030
Global RNA Sample Preparation Market Insights Forecast to 2030
Global DNA Vaccines Market Insights Forecast to 2030
Global mRNA Therapy Market Research Report 2024
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global DNA RNA Extraction System Market Insights Forecast to 2030
Global RNA Therapeutics Market Research Report 2024
RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Purification Market Insights Forecast to 2030
RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Extraction Reagents Market Insights Forecast to 2030
Global RNA Next Generation Sequencing Market Research Report 2024

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions